Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul;71(5):420-9.
doi: 10.1007/s00393-012-0990-z.

[Safety of Immunosuppressants]

[Article in German]
Affiliations

[Safety of Immunosuppressants]

[Article in German]
O Psenak et al. Z Rheumatol. .

Abstract

Metabolism: Cyclosporin A and leflunomide may increase the blood pressure, whereas administration of prednisolone and tacrolimus may cause hyperglycemia. Azathioprine, chloroquine, methotrexate and mycophenolate mofetil seem to be metabolically neutral. Tocilizumab and tumor necrosis factor (TNF) alpha blockers have a negative effect on the lipid profile.

Infections: The overall infection risk for prednisolone is estimated to be 1.3. This risk for methotrexate is also 1.3 compared to other disease modifying antirheumatic drugs (DMARDs). Regarding biologics, the highest risk of serious infections was associated with certolizumab pegol and tocilizumab, in contrast to abatacept and rituximab which showed the lowest risk. CANCER RISK: Azathioprine and cyclosporin A are associated with a markedly increased risk of non-melanoma skin cancer. According to the RABBIT registry no significant increase in tumor rate has been reported for biologics. PREGNANCY: Azathioprine, chloroquine, cyclosporin A, prednisolone, sulfasalazine, tacrolimus and cyclophosphamide (only after the second trimester) may be administered during pregnancy. Biologics should be avoided unless there is a treatment need in cases of uncontrolled disease activity. BREAST FEEDING: Only chloroquine, prednisolone, sulfasalazine and tacrolimus may be taken during breast feeding. There are insufficient data on the safety of biologics.

Comment in

  • [Safety of immunosuppressants].
    Fischer-Betz R. Fischer-Betz R. Z Rheumatol. 2013 Mar;72(2):189. doi: 10.1007/s00393-012-1055-z. Z Rheumatol. 2013. PMID: 23223872 German. No abstract available.
  • [Reply].
    Psenak O. Psenak O. Z Rheumatol. 2013 Mar;72(2):190. Z Rheumatol. 2013. PMID: 23627005 German. No abstract available.

Similar articles

See all similar articles

References

    1. Ann Rheum Dis. 2007 Jun;66(6):815-7 - PubMed
    1. Arthritis Rheum. 2009 May 15;61(5):587-92 - PubMed
    1. Teratology. 2002 May;65(5):240-61 - PubMed
    1. Birth Defects Res A Clin Mol Teratol. 2003 Dec;67(12):968-70 - PubMed
    1. Z Rheumatol. 2009 Mar;68(2):169-73 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

Feedback